[1] 俞亚转,孙晓宁.胃食管反流病患病影响因素的研究[J].胃肠病学和肝病学杂志,2019,28(10):1174-1178. [2] 胡秀娟.莫沙必利与埃索美拉唑联合氟哌噻吨美利曲辛片治疗难治性胃食管反流病的临床研究[J].中国基层医药,2019,26(17):2135-2138. [3] 王颖,席佳韵,宗丽春,等.低频神经肌肉电刺激联合巴氯芬治疗脑卒中偏瘫伴肌痉挛患者的疗效观察[J].实用心脑肺血管病杂志,2018,26(12):80-83. [4] DELOOSE E, DEPOORTERE I, HOON J D,et al. Manometric evaluation of the motilin receptor agonist camicinal (GSK962040) in humans[J].Neurogastroent Motil,2017, 30(2):e13173. [5] 中华医学会消化病学分会.2014年中国胃食管反流病专家共识意见[J].中华消化杂志,2014,34(10):649-661. [6] 刘培培,王洛伟.胃食管反流病的最新治疗进展[J].中华消化内镜杂志,2018,35(12):950-954. [7] 陈惠弟,张亚坤,许小鑫,等.某院胃食管反流病诊疗现状分析[J].胃肠病学,2019,24(4):230-234. [8] FATIMA H T. Efficacy of omeprazole/sodium bicarbonate treatment in gastroesophageal reflux disease: a systematic review[J].Medwave,2018, 18(2):e7179. [9] AMALACHUANDRAN J, SIMON S, ELANGOVEN I, et al. Scintigraphic evaluation of esophageal motility and gastroesophageal reflux in patients presenting with upper respiratory tract symptoms[J].Indian J Nucl Med,2018, 33(1):25-31. [10] 韦华胜,许保,杨月才.莫沙必利及奥美拉唑联合治疗老年反流性食管炎的临床效果[J].现代消化及介入诊疗,2018,23(5):577-580. [11] 田书瑞,胡志伟,吴继敏, 等.胃食管阀瓣分级与胃食管反流病的相关性[J].中华消化杂志,2019,39(4):257-260. [12] 黄静,吴绍英.巴氯芬治疗儿童难治性胃食管反流性咳嗽40例临床评价[J].中国药业,2015,5(17):37-38. [13] ASIM M, MATTHEW J R. Gastroesophageal reflux disease and aerodigestive disorders[J].Curr Probl Pediatr Adolesc Health Care,2018,48(3):85-98. [14] 郭华,张靖,田静,等.莫沙必利联合奥美拉唑对老年功能性消化不良患者胃肠激素与胃肠动力的影响[J].国际消化病杂志,2018,38(2):121-125.
2021, Vol. 38 
